Amarin | AMRN - Frais De Vente Et D'Administration

Prix De L'Action
14.31
Variation Quotidienne
-0.28 -1.92%
Mensuellement
-2.52%
Annuel
37.20%
Q2 Prévisions
13.88




Frais De Vente Et D'Administration Changement Date
AbbVie USD 3.89B 325M 2025-12
Alnylam Pharmaceuticals USD 285.06M 22.47M 2025-12
Amarin USD 18.97M 1.03M 2025-12
AstraZeneca USD 4.61B 4.46B 2025-12
BioCryst Pharmaceuticals USD 95.78M 12.77M 2025-12
DBV Technologies USD 3.63M 3.18M 2025-09
Esperion Therapeutics USD 39.42M 456K 2025-12
GlaxoSmithKline GBP 2.68B 518M 2025-12
Halozyme Therapeutics USD 64.64M 27.11M 2025-12
Heron Therapeutics USD 23.74M 605K 2025-12
Ionis Pharmaceuticals USD 130M 43.43M 2025-12
Nektar Therapeutics USD 10.17M 10.17M 2025-12
Neurocrine Biosciences USD 301.8M 10.2M 2025-12
Novartis USD 3.44B 128M 2025-12